Tim Barry ’93 co-founded a health care company that offers primary care, multispecialty and urgent care options to 1.6 million patients throughout the U.S.
Blocking the formation of filaments – multi-enzyme structures that fuel cancer activity – may offer new ways to control cancer cell proliferation, according to a new study led by Cornell researchers.
Researchers have developed an AI tool that uses machine learning and large language models to identify treatment options based on patients’ diagnoses, demographic information and priorities.
Cornell food scientists show that a standard quality test used for raw, organic milk is insufficient for distinguishing between specific groups of bacteria -- suggesting that criteria needs updating.
Professor Sean Nicholson, director of the Cornell Sloan Program in Health Administration, explores the future of biopharma with industry experts in the Keynote webcast “Bringing New Science to Market.”
Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.
Cornell researchers have developed a robotic feeding system that uses computer vision, machine learning and multimodal sensing to safely feed people with severe mobility limitations, including those with spinal cord injuries, cerebral palsy and multiple sclerosis.
The research reveals how dietary tryptophan – an amino acid – can be broken down by gut bacteria into small molecules called metabolites that ultimately keep E. coli from colonizing in the gut.